We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+8.41%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.63B
AUM Growth
+$112M
(+3.2%)
Cap. Flow
-$90.1M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
372
New
63
Increased
77
Reduced
55
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$89.9M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$70.6M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$66.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$57.9M |
| 5 |
SLB Ltd
SLB
|
+$57.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$73.3M |
| 2 |
TJX Companies
TJX
|
+$73M |
| 3 |
Costco
COST
|
+$71.1M |
| 4 |
Revvity
RVTY
|
+$52.1M |
| 5 |
Mastercard
MA
|
+$52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.56% |
| 2 | Energy | 18.38% |
| 3 | Consumer Discretionary | 14.24% |
| 4 | Industrials | 13.62% |
| 5 | Healthcare | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APC
301
DELISTED
Anadarko Petroleum
APC
| $219K | 0.01% |
2,000
| – | – |
|
302
Medtronic
MDT
$112B
| $217K | 0.01% |
3,400
| – | – |
|
|
PSXP
303
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $212K | 0.01% |
2,800
| – | – |
|
|
CFN
304
DELISTED
CAREFUSION CORPORATION
CFN
| $206K | 0.01% |
4,650
| – | – |
|
|
AGN
305
DELISTED
Allergan Inc
AGN
| $203K | 0.01% |
1,200
| – | – |
|
306
Pfizer
PFE
$143B
| $193K | 0.01% |
6,851
-1,313,820
| -99% | -$37.5M |
|
307
Microsoft
MSFT
$2.9T
| $167K | ﹤0.01% |
4,000
| – | – |
|
308
Caterpillar
CAT
$361B
| $163K | ﹤0.01% |
1,500
| – | – |
|
309
PepsiCo
PEP
$196B
| $143K | ﹤0.01% |
1,600
| – | – |
|
310
Deere & Co
DE
$165B
| $127K | ﹤0.01% |
1,400
| – | – |
|
311
Cisco
CSCO
$443B
| $124K | ﹤0.01% |
5,000
| – | – |
|
312
AbbVie
ABBV
$465B
| $102K | ﹤0.01% |
1,800
| – | – |
|
313
McDonald's
MCD
$193B
| $81K | ﹤0.01% |
800
| – | – |
|
314
Abbott
ABT
$188B
| $74K | ﹤0.01% |
1,800
-40,000
| -96% | -$1.57M |
|
|
WBA
315
DELISTED
Walgreens Boots Alliance
WBA
| $74K | ﹤0.01% |
1,000
| – | – |
|
316
Stryker
SYK
$135B
| $59K | ﹤0.01% |
700
| – | – |
|
317
Tapestry
TPR
$30.3B
| $51K | ﹤0.01% |
1,500
| – | – |
|
318
Antero Resources
AR
$10.9B
| – | – |
-77,350
| Closed | -$4.84M |
|
319
Biogen
BIIB
$30.9B
| – | – |
-134,770
| Closed | -$41.2M |
|
320
CoStar Group
CSGP
$12.2B
| – | – |
-310,080
| Closed | -$5.79M |
|
321
DexCom
DXCM
$29B
| – | – |
-821,480
| Closed | -$8.49M |
|
322
Emergent Biosolutions
EBS
$379M
| – | – |
-180,225
| Closed | -$4.55M |
|
323
8x8 Inc
EGHT
$279M
| – | – |
-653,382
| Closed | -$7.06M |
|
324
iShares MSCI Japan ETF
EWJ
$21.2B
| – | – |
-125,000
| Closed | -$5.67M |
|
325
Hexcel
HXL
$7.97B
| – | – |
-201,309
| Closed | -$8.77M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2014 Portfolio in Review
As of Q2 2014, Castleark Management held 372 positions worth $3.63B, up 3.2% from $3.52B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Castleark Management's Q2 2014 filing shows 63 new, 77 increased, 55 reduced and 55 closed positions. Its largest new stake was Charles Schwab: 2,541,890 shares worth $68.5M. The largest sale was Xilinx Inc, an estimated $73.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
- Castleark Management's largest Q2 2014 buy was Charles Schwab: 2,541,890 shares worth $68.5M.
- Castleark Management added most to Intel in Q2 2014, an estimated $89.9M increase.
- Castleark Management's biggest Q2 2014 reduction was TJX Companies, cutting an estimated $73M.
- Castleark Management fully exited Xilinx Inc in Q2 2014, selling an estimated $73.3M.
- Castleark Management's ten largest holdings make up 24% of its $3.63B portfolio in Q2 2014.
- Castleark Management opened 63 new positions and closed 55 in Q2 2014.
- Castleark Management's portfolio value rose 3.2% quarter-over-quarter to $3.63B.
Based on Castleark Management's 13F filing for Q2 2014, filed 15 Aug 2014.